MBIO
Price
$0.44Alerts
Change
-$0.00 (-0.00%)
Updated
Nov 12, 12:25 PM (EDT)
Capitalization
3.01M
Intraday BUY SELL Signals
OKYO
Price
$1.42Alerts
Change
+$0.04 (+2.90%)
Updated
Nov 11 closing price
Capitalization
75.05M
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MBIO vs OKYO

MBIO vs OKYO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MBIO vs. OKYO commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBIO is a Hold and OKYO is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MBIO with price predictions
Nov 11, 2026

MBIO in +5.73% Uptrend, rising for three consecutive days on November 02, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MBIO advanced for three days, in 147 of 191 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MBIO's RSI Indicator exited the oversold zone, 44 of 59 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on MBIO as a result. In 57 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

The Moving Average Convergence Divergence (MACD) for MBIO just turned positive on October 27, 2026. Looking at past instances where MBIO's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 31 cases where MBIO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MBIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

MBIO broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MBIO entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. MBIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.398) is normal, around the industry mean (3.498). P/E Ratio (-0.945) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for OKYO with price predictions
Nov 11, 2026

Aroon Indicator for OKYO shows an upward move is likely

OKYO's Aroon Indicator triggered a bullish signal on October 30, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 95 similar instances where the Aroon Indicator showed a similar pattern. In 86 of the 95 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 47 cases where OKYO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

OKYO moved above its 50-day moving average on November 11, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for OKYO crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 74%.

Following a +10.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where OKYO advanced for three days, in 130 of 151 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

OKYO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OKYO as a result. In 71 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for OKYO turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 31 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OKYO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. OKYO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.381) is normal, around the industry mean (3.498). P/E Ratio (-3.837) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
MBIO vs OKYO: Fundamental Ratings
MBIO
OKYO
OUTLOOK RATING
1..100
1183
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10059
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6371
P/E GROWTH RATING
1..100
9851
SEASONALITY SCORE
1..100
4650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OKYO's Valuation (85) in the null industry is in the same range as MBIO (88) in the Pharmaceuticals Major industry. This means that OKYO’s stock grew similarly to MBIO’s over the last 12 months.

OKYO's Profit vs Risk Rating (59) in the null industry is somewhat better than the same rating for MBIO (100) in the Pharmaceuticals Major industry. This means that OKYO’s stock grew somewhat faster than MBIO’s over the last 12 months.

OKYO's SMR Rating (98) in the null industry is in the same range as MBIO (98) in the Pharmaceuticals Major industry. This means that OKYO’s stock grew similarly to MBIO’s over the last 12 months.

MBIO's Price Growth Rating (63) in the Pharmaceuticals Major industry is in the same range as OKYO (71) in the null industry. This means that MBIO’s stock grew similarly to OKYO’s over the last 12 months.

OKYO's P/E Growth Rating (51) in the null industry is somewhat better than the same rating for MBIO (98) in the Pharmaceuticals Major industry. This means that OKYO’s stock grew somewhat faster than MBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MBIOOKYO
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
66%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (MBIO: $0.44 vs. OKYO: $1.42)
Brand notoriety: MBIO and OKYO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBIO: 91% vs. OKYO: 101%
Market capitalization -- MBIO: $3.01M vs. OKYO: $75.05M
MBIO [@Biotechnology] is valued at $3.01M. OKYO’s [@Biotechnology] market capitalization is $75.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBIO’s FA Score shows that 0 FA rating(s) are green while OKYO’s FA Score has 0 green FA rating(s).

  • MBIO’s FA Score: 0 green, 5 red.
  • OKYO’s FA Score: 0 green, 5 red.
According to our system of comparison, OKYO is a better buy in the long-term than MBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBIO’s TA Score shows that 4 TA indicator(s) are bullish while OKYO’s TA Score has 6 bullish TA indicator(s).

  • MBIO’s TA Score: 4 bullish, 4 bearish.
  • OKYO’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, OKYO is a better buy in the short-term than MBIO.

Price Growth

MBIO (@Biotechnology) experienced а +5.05% price change this week, while OKYO (@Biotechnology) price change was -0.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.66%. For the same industry, the average monthly price growth was +1.65%, and the average quarterly price growth was -13.40%.

Reported Earning Dates

OKYO is expected to report earnings on Dec 02, 2026.

Industries' Descriptions

@Biotechnology (+11.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and XRTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and XRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
+2.90%
XRTX - OKYO
30%
Poorly correlated
+4.72%
SPRB - OKYO
27%
Poorly correlated
-1.00%
BEAM - OKYO
27%
Poorly correlated
+2.62%
MBIO - OKYO
27%
Poorly correlated
-3.06%
INTS - OKYO
26%
Poorly correlated
+6.15%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NEBX9.572.30
+31.64%
Tradr 2X Long NBIS Daily ETF (NEBX)
REMX53.131.29
+2.49%
VanEck Rare Earth and Strategic Metals ETF (REMX)
DVQQ29.610.51
+1.75%
WEBs QQQ Defined Volatility ETF (DVQQ)
YCS56.070.76
+1.36%
ProShares UltraShort Yen (YCS)
SPDN8.55-0.11
-1.27%
Direxion Daily S&P 500 Bear 1X ETF (SPDN)